Wenmin Cao

1.6k total citations · 1 hit paper
35 papers, 1.3k citations indexed

About

Wenmin Cao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenmin Cao has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenmin Cao's work include Nanoplatforms for cancer theranostics (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Wenmin Cao is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Wenmin Cao collaborates with scholars based in China, Ethiopia and Saint Kitts and Nevis. Wenmin Cao's co-authors include Hongqian Guo, Xiaozhi Zhao, Tingsheng Lin, Hui Wei, Bo Jiang, Sheng Zhao, Wei Chen, Hang Yu, Hang Yu and Meng Ding and has published in prestigious journals such as Nature Communications, Biomaterials and Scientific Reports.

In The Last Decade

Wenmin Cao

33 papers receiving 1.3k citations

Hit Papers

O2-generating MnO2 nanoparticles for enhanced photodynami... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia
    2018 256 citations Tingsheng Lin, Xiaozhi Zhao et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenmin Cao China 19 522 458 314 295 234 35 1.3k
Meng Jia China 19 482 0.9× 427 0.9× 166 0.5× 121 0.4× 130 0.6× 36 1.4k
Yuchan You China 14 316 0.6× 433 0.9× 166 0.5× 79 0.3× 142 0.6× 21 897
Chenying Lu China 21 530 1.0× 339 0.7× 402 1.3× 326 1.1× 141 0.6× 75 1.3k
Chaoqiang Qiao China 13 498 1.0× 370 0.8× 159 0.5× 85 0.3× 158 0.7× 24 940
Jingyi Sheng China 16 694 1.3× 223 0.5× 91 0.3× 395 1.3× 316 1.4× 31 1.2k
Jianhao Lai China 11 261 0.5× 609 1.3× 213 0.7× 72 0.2× 240 1.0× 18 1.0k
Shiji Fang China 21 828 1.6× 252 0.6× 487 1.6× 490 1.7× 76 0.3× 63 1.6k
Jia Huang China 20 457 0.9× 203 0.4× 98 0.3× 158 0.5× 69 0.3× 52 1.4k

Countries citing papers authored by Wenmin Cao

Since Specialization
Citations

This map shows the geographic impact of Wenmin Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmin Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmin Cao more than expected).

Fields of papers citing papers by Wenmin Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenmin Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmin Cao. The network helps show where Wenmin Cao may publish in the future.

Co-authorship network of co-authors of Wenmin Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Wenmin Cao. A scholar is included among the top collaborators of Wenmin Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenmin Cao. Wenmin Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Jie, Qi Deng, Wei Lin, et al.. (2025). Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway. European Journal of Pharmacology. 1003. 177887–177887.
2.
Chen, Xiaohong, Wenli Diao, Wenmin Cao, et al.. (2025). The N6‐methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression. FEBS Journal. 292(13). 3477–3493.
3.
Li, Xianglong, Wenmin Cao, Xinwu Wang, et al.. (2023). Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer. Journal of Controlled Release. 363. 221–234. 61 indexed citations
4.
Du, Lin, Baojun Wang, Weixu Chen, et al.. (2023). LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway. Cancer Letters. 578. 216463–216463. 6 indexed citations
5.
Wang, Guoli, et al.. (2023). Stress granules affect the sensitivity of renal cancer cells to sorafenib by sequestering and stabilizing COX‑2 mRNA. Oncology Letters. 25(6). 274–274. 4 indexed citations
6.
Liu, Shujie, Xiaozhi Zhao, Yuhang Li, et al.. (2023). ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy (Adv. Healthcare Mater. 21/2023). Advanced Healthcare Materials. 12(21). 1 indexed citations
7.
Gao, Jie, Baojun Wang, Hongwei Shen, et al.. (2023). MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma. Redox Biology. 68. 102956–102956. 15 indexed citations
8.
Wang, Guoli, Xin He, Wenmin Cao, et al.. (2023). WDR4 promotes the progression and lymphatic metastasis of bladder cancer via transcriptional down-regulation of ARRB2. Oncogenesis. 12(1). 47–47. 3 indexed citations
9.
Jiang, Bo, Xiaozhi Zhao, Wei Chen, et al.. (2022). Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation. Nature Communications. 13(1). 4141–4141. 27 indexed citations
10.
Ding, Meng, Xiaozhi Zhao, Wenli Diao, et al.. (2022). Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p. Cell Death Discovery. 8(1). 439–439. 25 indexed citations
11.
Zhang, Wenlong, Xin He, Wenmin Cao, et al.. (2022). Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis. Journal of Hematology & Oncology. 15(1). 93–93. 29 indexed citations
12.
Lu, Qun, Wei Chen, Wenli Diao, et al.. (2022). circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5. Cell Death Discovery. 8(1). 243–243. 17 indexed citations
13.
Qin, Haixiang, Lin Du, Bo Jiang, et al.. (2022). Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers. Cancer Cell International. 22(1). 101–101. 15 indexed citations
14.
Qin, Haixiang, Yang Yang, Bo Jiang, et al.. (2021). SOX9 in prostate cancer is upregulated by cancer‐associated fibroblasts to promote tumor progression through HGF/c‐Met‐FRA1 signaling. FEBS Journal. 288(18). 5406–5429. 20 indexed citations
15.
Qin, Haixiang, Bo Jiang, Wenfeng Lu, et al.. (2021). KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Letters. 522. 1–13. 123 indexed citations
16.
Lin, Tingsheng, Qing Zhang, Ahu Yuan, et al.. (2020). Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment. Theranostics. 10(17). 7683–7696. 39 indexed citations
17.
Jiang, Bo, Wei Chen, Haixiang Qin, et al.. (2019). TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma. Cancer Letters. 449. 76–86. 19 indexed citations
18.
Yu, Hang, Tingsheng Lin, Wei Chen, et al.. (2019). Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis. Biomaterials. 219. 119368–119368. 104 indexed citations
19.
Diao, Wenli, Wei Chen, Wenmin Cao, et al.. (2019). Astaxanthin protects against renal fibrosis through inhibiting myofibroblast activation and promoting CD8+ T cell recruitment. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(9). 1360–1370. 26 indexed citations
20.
Lin, Tingsheng, Ahu Yuan, Xiaozhi Zhao, et al.. (2017). Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer. Acta Biomaterialia. 53. 427–438. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng Jia Breakdown of academic impact, for papers by Yuchan You Breakdown of academic impact, for papers by Chenying Lu Breakdown of academic impact, for papers by Chaoqiang Qiao Breakdown of academic impact, for papers by Jingyi Sheng Breakdown of academic impact, for papers by Jianhao Lai Breakdown of academic impact, for papers by Shiji Fang Breakdown of academic impact, for papers by Jia Huang
Rankless by CCL
2026